California International STI Consortium (CISC)
The primary objective of the California-International Sexually
Transmitted Infection (STI) Consortium (CISC) is to provide the
infrastructure, capacity, and scientific leadership to design and
conduct state-of-the-art intervention trials to prevent and treat
STIs worldwide. CISC combines a multidisciplinary and multinational
approach to our research.
Our consortium brings together many of the world’s leading
researchers from some of the country’s most esteemed research and
public health institutions. CISC combines expertise from California:
the University of California San Francisco (UCSF) as the master
contractor; San Francisco Department of Public Health (SFDPH);
University of California Los Angeles (UCLA); Los Angeles Department
of Health Services (LADHS); State of California Department of Health
Services, STD Control Branch; and Stanford University; with
international collaborating institutions in seven countries. Our
International partners are divided into two tiers; Consortium
Partners who will participate in the CISC Executive Committee and
act as full subcontractors; and Consortium Collaborators who will
expand CISC’s geographic reach and participate in clinical trials as
deemed necessary.
CISC Consortium Partners include: Canada (University of Toronto
(UT)); China (National Center for AIDS/STD Control and Prevention);
Kenya (Kenya Medical Research Institute (KEMRI)) and the University
of Nairobi (UN)); Zimbabwe (University of Zimbabwe (UZ)); and Mexico
(National Institute of Public Health (INSP). CISC Collaborators
include Brazil (Oswaldo Cruz Institute) and Viet Nam (Hanoi Medical
University).
|